WVE WAVE Life Sciences

Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a virtual analyst-led fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference. The presentation will be available to view beginning on Monday, September 11, 2023, at 7:00 a.m. ET.

A live webcast of this presentation will be available on the Investor Relations page of the Wave Life Sciences website at . Replay of this presentation will be archived and available on the site for a limited time following the event.

About Wave Life Sciences

Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit  and follow Wave on Twitter .

Investor Contact:

Kate Rausch



Media Contact:

Alicia Suter





EN
06/09/2023

Underlying

WVEWAVE Life Sciences

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WAVE Life Sciences

David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Geoffrey Von Der Ahe
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong
XNCR XENCOR INC.
NVCR NOVOCURE LTD.
MNKD MANNKIND CORP.
FATE FATE THERAPEUTICS INC
BIIB BIOGEN INC.
ARDX ARDELYX INC
WVE WAVE LIFE SCIENCES
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
ISR ISORAY
APRE APREA THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
ZNTL ZENTALIS PHARMACEUTICALS
TVTX TRAVERE THERAPEUTICS INC
RZLT REZOLUTE
NUVB NUVATION BIO INC (A)
NUVL NUVALENT INC
MAZE MAZE THERAPEUTICS INC
JBIO JADE BIOSCIENCES INC
10/18/25 October 18, 2025 1 EN
Wedbush Research
  • Wedbush Research
KMX CARMAX INC.
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
FATE FATE THERAPEUTICS INC
CRM SALESFORCE.COM INC.
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
AMD ADVANCED MICRO DEVICES INC.
GM GENERAL MOTORS COMPANY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SMCI SUPER MICRO COMPUTER
ACET INC.
RZLT ADICET BIO INC
SANA REZOLUTE
STX SANA BIOTECHNOLOGY
GFS SEAGATE TECHNOLOGY HLDGS PLC
ARTV GLOBALFOUNDRIES INC
RNAC ARTIVA BIOTHERAPEUTICS INC
CARTESIAN THERAPEUTICS INC
10/16/25 October 16, 2025 1 EN
Yun Zhong
  • Yun Zhong
WVE WAVE Life Scien...

KOL Call Takeaways: WVE-006 Had A Good Start In AATD

Measuring Actual Outcomes Would be More Important. The level of protection required by each patient could be different. For some patients (e.g., those with more inflammation), a higher level (i.e., higher dose of augmentation therapy) could be required. Therefore, according to Dr. Hogarth, instead

WVE WAVE LIFE SCIENCES
10/16/25 October 16, 2025 1 EN
Wedbush Research
  • Wedbush Research
SHOP SHOPIFY INC.
WDC WESTERN DIGITAL CORPORATION
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
ETSY ETSY INC.
EBAY EBAY INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ACRS ACLARIS THERAPEUTICS INC.
NFLX NETFLIX INC.
INOD INNODATA
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
ANAB ANAPTYSBIO INC.
ROKU ROKU INC. CLASS A
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
ZG ZILLOW GROUP INC. CLASS A
BKNG BOOKING HOLDINGS INC.
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
SMCI SUPER MICRO COMPUTER
BEAM INC.
DASH BEAM THERAPEUTICS
ABNB DOORDASH
STX AIRBNB INC. CLASS A
ATXS SEAGATE TECHNOLOGY HLDGS PLC
GFS ASTRIA THERAPEUTICS INC
CINT GLOBALFOUNDRIES INC
YOU CI&T INC
PRME CLEAR SECURE INC
CART PRIME MEDICINE INC
MAPLEBEAR INC.
10/15/25 October 15, 2025 1 EN
David Nierengarten ... (+4)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
  • Yun Zhong
WVE WAVE Life Scien...
BEAM Beam Therapeuti... ... (+3)

KOL Call Today @ 1PM ET: Just Breathe: Genetic Medicines in AATD

Dr. Hogarth completed his residency in internal medicine (1998-2001) and his fellowship in pulmonary and critical care medicine (2001-2004) before joining the University of Chicago faculty as an Assistant Professor of Medicine (2004-2014). He was later promoted to Associate Professor of Medicine (2

WVE WAVE LIFE SCIENCES
BEAM BEAM THERAPEUTICS
PRME PRIME MEDICINE INC
10/15/25 October 15, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch